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ABSTRACT
Cytomegaloviruses (CMVs) establish chronic infections that spread from a primary entry site to secondary vascular sites, such as
the spleen, and then to tertiary shedding sites, such as the salivary glands. Human CMV (HCMV) is difficult to analyze, because
its spread precedes clinical presentation. Murine CMV (MCMV) offers a tractable model. It is hypothesized to spread from pe-
ripheral sites via vascular endothelial cells and associated monocytes. However, viral luciferase imaging showed footpad-inocu-
latedMCMV first reaching the popliteal lymph nodes (PLN). PLN colonization was rapid and further spread was slow, implying
that LN infection can be a significant bottleneck. Most acutely infected PLN cells were CD169 subcapsular sinus macrophages
(SSM). Replication-deficient MCMV also reached them, indicating direct infection. Many SSM expressed viral reporter genes,
but few expressed lytic genes. SSM expressed CD11c, andMCMVwith a cre-sensitive fluorochrome switch showed switched in-
fected cells in PLN of CD11c-cre mice but yielded little switched virus. SSM depletion with liposomal clodronate or via a CD169-
diphtheria toxin receptor transgene shifted infection to ER-TR7 stromal cells, increased virus production, and accelerated its
spread to the spleen. Therefore, MCMV disseminated via LN, and SSM slowed this spread by shielding permissive fibroblasts and
poorly supporting viral lytic replication.
IMPORTANCE
HCMV chronically infects most people, and it can cause congenital disability and harm the immunocompromised. Amajor goal
of vaccination is to prevent systemic infection. How this is established is unclear. Restriction to humans makes HCMV difficult
to analyze. We show that peripheral MCMV infection spreads via lymph nodes. Here, MCMV infected filtering macrophages,
which supported virus replication poorly. When these macrophages were depleted, MCMV infected susceptible fibroblasts and
spread faster. The capacity of filtering macrophages to limit MCMV spread argued that their infection is an important bottleneck
in host colonization andmight be a good vaccine target.
Human cytomegalovirus (HCMV) chronically infects morethan 90% of the world’s population. Latent virus is detectable
in circulating monocytes; there also may be persistent stromal
infection, and infectious virus is shed long term in secretions such
as saliva (1). While most infections are asymptomatic, immune
control can require substantial resources (2); immunocompro-
mised patients suffer multiorgan disease, and HCMV is a leading
cause of congenital disability. Therefore, better control would
improve human health. So far, vaccines have failed to prevent
infection or reduce long-term viral loads (3). One problem is
that early infection events, which are key vaccine targets, re-
main ill defined. Virus behavior is cell type dependent, so an
important unknown is which cell types HCMV infects first
when colonizing new hosts.
Sporadic, asymptomatic HCMV transmission makes early in-
fection hard to study (1). It is important to recognize, therefore,
that HCMV is far from unique: CMVs colonize all mammals, and
their species restrictions imply that this colonization predates
most mammalian speciation. While virus-host pairs have since
coevolved separately, even divergent viral genes often have equiv-
alent functions in, for example, immune evasion (4), apoptosis
suppression (5), and tropism switching (6). Therefore, a core
CMV life cycle seems to be conserved. Consequently, animal
CMVs can provide important information for understanding how
HCMV works. Mice provide the main experimental model of
mammalian biology, so MCMV (7) has particular value for defin-
ing how host and virus interact in vivo.
Natural MCMV entry routes remain ill defined. Transmission
in breast milk is possible (8), but orally inoculated virus has not
infected the neonatal gastrointestinal tract (9). MCMV can infect
the lungs, but delivery here relies on inoculation under anesthesia
(10) and needs further validation to qualify as natural entry. Most
experimental infections have used intraperitoneal (i.p.) or intra-
venous (i.v.) virus inoculations, which seed rapidly to the liver and
spleen (11) and probably also other sites. A monocyte-associated
viremia follows (12), and MCMV spread to the salivary glands is
monocyte dependent (13). Tracking floxed MCMV by recombi-
nation in cre transgenic mice shows that i.v. virions disseminate
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via a TIE2 cell (14), possibly a vascular endothelial cell, and also
possibly a radio-resistant myeloid cell (15).
While i.p. and i.v. inoculations have informed us about
MCMV spread from vascular sites, they reach the blood directly
and bypass the normal need to spread from a peripheral, primary
site. Intrafootpad (i.f.) inoculations offer more scope to study this
earlier phase of host colonization. Natural infections may not be
subcutaneous, but i.f. inoculation allows controlled and repro-
ducible virion delivery to a peripheral site. i.f. MCMV is hypoth-
esized to enter the blood via vascular endothelial cells and patrol-
ling monocytes (16). However, such infection has not been
visualized directly, and the prediction that i.f. virus should seed
rapidly to the spleen has not been tested. An alternative possibility
is that i.f. MCMV reaches the blood via lymphatics. This would
bring it into contact with popliteal lymph node (PLN) subcapsular
sinus macrophages (SSM) (17). Several viruses have been tracked
to SSM (18–20). SSM infection limits vesicular stomatitis virus
(VSV) access to neurons, thereby reducing disease (19); however,
VSV normally infects ungulates, so the physiological relevance of
its behavior in murine SSM is unclear. In contrast, MCMV is a
natural murine pathogen that exploits myeloid cells for dissemi-
nation. We established here how it spreads from the footpad.
MATERIALS AND METHODS
Mice. BALB/c, C57BL/6J, CD11c-Cre (21), and CD169-diphtheria toxin
(DTx) receptor (DTR) mice (22) were maintained at University of
Queensland animal units and used when they were 6 to 12 weeks old.
Animal experiments were approved by the University of Queensland An-
imal Ethics Committee in accordance with Australian National Health
and Medical Research Council (NHMRC) guidelines. Anesthesia was by
isoflurane inhalation. Viruses were administered (106 PFU) either i.f. (50
l) or i.p. (100 l). For luciferase imaging, mice were given 2 mg D-
luciferin i.p., anesthetized by isoflurane inhalation, and monitored for
light emission by charge-coupled device camera scanning (Xenogen IVIS-
200). To deplete phagocytic cells, mice were injected i.f. twice with 50 l
clodronate-loaded liposomes (http://clodronateliposomes.org/) (23) 3 to
5 days before infection. To deplete CD169 cells, CD169-DTR mice were
injected i.p. twice with 100 ng diphtheria toxin (Sigma Chemical Co.) 1 to
3 days before infection. Depletion was essentially complete, as described
previously (24). Mice were killed by exposure to a rising concentration of
CO2 or by cervical dislocation.
Cells and viruses. The detection of infected cells was facilitated by
reporter viruses. For live imaging (MCMV-LUC), an HCMV IE1 promoter-
driven luciferase expression cassette was inserted into m157 of a bacterial
artificial chromosome (BAC)-cloned MCMV strain Smith genome that
also was repaired for MCK2 expression (25). For fluorescent labeling of
infected cells (MCMV-GR), an HCMV IE1 promoter-driven cassette was
inserted into m157 of MCMV strain K181 by homologous recombina-
tion. This cassette, kindly provided by Alice McGovern (University of
Queensland), encoded a floxed enhanced green fluorescent protein
(EGFP) coding sequence upstream of nuclear-targeted tdTomato. Thus,
exposure to cre switched viral fluorochrome expression irreversibly from
EGFP to tdTomato. MCMV deleted of the essential virion glycoprotein L
(gL) by inserting an HCMV IE1 promoter-driven LacZ cassette into M115
of strain K181 was propagated on gL-expressing NIH 3T3 cells (26). All
other viruses were propagated on unmodified NIH 3T3 cells (American
Type Culture Collection CRL-1658). Cells were grown in Dulbecco’s modi-
fied Eagle’s medium supplemented with 2 mM glutamine, 100 IU/ml peni-
cillin, 100g/ml streptomycin, and 10% fetal calf serum. Virus was harvested
from infected cells by low-speed centrifugation (500 g, 10 min) to remove
cell debris and then by ultracentrifugation (35,000 g, 2 h).
Plaque assays. Infectious virus from cell culture or organ homoge-
nates was quantified by plaque assay on murine embryonic fibroblasts
(27). To detect gL-deficient MCMV, cells infected in the single round of
replication were identified by fixation (1% formaldehyde, 30 min) and
then incubation (2 h, 37°C) with 5-bromo-4-chloro-3-indolyl--D-galac-
topyranoside (1 mg/ml) in 100 mM sodium phosphate, pH 7.3, 1.3 mM
magnesium chloride, 3 mM potassium ferricyanide, 3 mM potassium
ferrocyanide (X-Gal).
Immunostaining. For immunofluorescence, organs were fixed in 1%
formaldehyde–10 mM sodium periodate–75 mM L-lysine (24 h, 4°C),
equilibrated in 30% sucrose (18 h, 4°C), and then frozen in OCT. Sections
(6 m) were air dried (1 h, 23°C), washed 3 in phosphate-buffered
saline (PBS), blocked with 0.3% Triton X-100 –5% normal goat serum (1
h, 23°C), and then incubated (18 h, 4°C) with combinations of primary
antibodies (Ab) from anti-EGFP (rabbit polyclonal Ab [PAb]), anti-
CD45R/B220 (rat monoclonal Ab [MAb] RA3-6B2), and F4/80 (rat MAb)
(all from Santa Cruz Biotechnology); -galactosidase (chicken PAb),
CD11c (hamster MAb N418), ER-TR7 (rat MAb), and CD68 (rat MAb;
FA-11) (all from AbCam); CD206 (rat MAb MR5D3) and CD169 (rat
MAb 3D6.112) (from Serotec); and anti-MCMV (rabbit PAb raised by
subcutaneous inoculation of rabbits with MCMV K181 propagated in
NIH 3T3 cells). For CD11c staining, fixed sections first were treated with
proteinase K (10 g/ml; 5 min, 23°C). After incubation, sections were
washed 3 in PBS, incubated (1 h, 23°C) with combinations of Alexa 568-
or Alexa 647-conjugated goat anti-rat IgG PAb, Alexa 488- or Alexa
568-conjugated goat anti-rabbit IgG PAb (Life Technologies), Alexa 647-
conjugated goat anti-hamster IgG PAb, and Alexa 488-conjugated goat
anti-chicken IgG PAb (Abcam), and then washed 3 in PBS, counter-
stained with Hoechst 33342, and mounted in ProLong gold (Life Tech-
nologies). Fluorescence was visualized with a Zeiss LCM510 confocal mi-
croscope and analyzed with Zen imaging software. To detect
-galactosidase, organs were fixed and frozen as described above. Air-
dried 6-m sections were washed 3 in PBS and incubated with X-Gal (2
h, 37°C). Sections were counterstained with neutral red and mounted in
VectaMount (Vector Laboratories).
Viral genome quantitation. DNA was extracted from organs or blood
(NucleoSpin tissue kit; Macherey-Nagel). MCMV genomic coordinates
4166 to 4252 were amplified by PCR (LightCycler 480 SYBR green; Roche)
and converted to genome copies by comparison with purified MCMV
genomic DNA amplified in parallel. Cellular DNA was quantified in the
same samples by PCR amplification of a-actin gene fragment, again with
template dilutions amplified in parallel. Viral DNA loads were normalized
by cellular DNA loads.
Statistical analysis. Data were analyzed using GraphPad Prism 6.0.
Experimental groups were compared by two-tailed Student’s t test with
Welch’s correction; multiple groups within experiments were compared
by two-way analysis of variance (ANOVA) test with Tukey’s multiple
comparison. Results with95% confidence were considered significant.
RESULTS
Visualization of MCMV spread by luciferase expression. We
used HCMV IE1 promoter-driven luciferase expression (MCMV-
LUC) to track global MCMV spread after i.f. inoculation (Fig. 1).
Live imaging (Fig. 1a and b) showed strong signals in the feet from
day 1 and signals in the neck from day 6. Postmortem imaging of
dissected organs (Fig. 1c and d) showed strong luciferase signals in
footpads and the draining popliteal lymph nodes (PLN) from day
1. Luciferase signals were hard to detect in spleens until day 6.
Neck signals were from the salivary glands. Occasional signals (ap-
proximately 1/5 mice) were observed in para-aortic LN from day 3
to day 6; none was observed in other LN or in the liver. Thus, i.f.
MCMV rapidly reached the PLN, but several days passed before
there was evidence of further, systemic spread. i.p. MCMV-LUC
(Fig. 1e) showed luciferase signals mainly in the omentum at day 5
postinoculation but also in the spleen, indicating that the spleen
could support early luciferase expression if virus reached it. There-
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fore, the PLN were the proximate target for i.f. virions and seemed
to restrict further, systemic spread.
Acute virus spread to PLN is not host or virus strain specific.
Plaque assays of tissues from i.f. MCMV-LUC-inoculated BALB/c
mice (Fig. 2a) showed high titers of infectious virus in footpads
from day 1 and in PLN from day 2. Infectious virus was not de-
tectable in spleens until day 3, and then only at low titers. Thus,
plaque assays supported the conclusion from luciferase imaging
that i.f. MCMV passes rapidly to the PLN and then slowly to the
spleen and salivary glands. Negligible titers of infectious virus
were recovered from blood. Quantitating viral DNA by PCR (Fig.
2b) showed a consistent picture: PLN DNA loads tracked those in
footpads but were 10- to 100-fold lower; those in the spleen and
the blood, while detectable above background, remained low. An
equivalent i.p. inoculation gave 10- to 100-fold more viral DNA in
blood (normalized by total DNA). Therefore, i.f. virus did not pass
freely into the blood. Indeed, the lack of infectious virus in blood
argued that much of the DNA detected here might have been
infected cell debris rather than viable viral genomes.
MCMV-LUC was derived from MCK2-repaired strain Smith
(28). Phenotypic differences are reported between Smith and the
other main laboratory strain, K181 (29); in addition, mouse
strains differ in susceptibility to MCMV infection (30). Therefore,
to test the generality of our results, we analyzed by plaque assay the
spread of i.f. K181 MCMV in C57BL/6 mice (Fig. 2c). The lucif-
erase expression cassette of MCMV-LUC disrupted m157, which
otherwise attenuates MCMV in Ly49H mouse strains such as
C57BL/6 (31). Therefore, our K181 MCMV also had an HCMV
IE1-driven expression cassette in m157 (MCMV-GR). This en-
coded floxed EGFP upstream of tdTomato, so in mice lacking
transgenic cre expression, as was the case here, MCMV-GR was
EGFP tdTomato. High titers of infectious virus were detected
in footpads from day 1 postinoculation onwards, with peak titers
at day 3. High titers of virus also were detected in PLN at days 1
and 3. As with MCMV-LUC, spleens did not yield infectious
MCMV-GR until day 3. Therefore, PLN infection consistently
preceded splenic infection, arguing that i.f.-inoculated MCMV
spreads primarily via lymphatics.
In situ analysis of PLN infection. PLN infection appeared to
impose a delay on the spread of i.f.-inoculated MCMV. To under-
stand better how this might work, we stained tissue sections for
viral HCMV IE1 promoter-driven EGFP expression and cell type
markers (Fig. 3a). The proportion all EGFP PLN cells colocaliz-
ing with each marker was quantified across 5 to 12 fields of view
for at least 3 mice (Fig. 3b). At day 1 postinoculation, EGFP was
expressed predominantly in cells around the LN margins and co-
FIG 1 Visualizing MCMV spread by luciferase imaging. (a) BALB/c mice were given MCMV-LUC i.f. (105 PFU). Infection was tracked serially by i.p. luciferin
injection and imaging light emission. Representative images are shown for days 1 (early infection) and 8 (after dissemination). (b) Mice were infected as described
for panel a. Light emission (photons/second/square centimeter/steradian [p.s1.cm2.sr1]) was quantitated by live imaging over 10 days. Circles show individ-
uals, and crosses shows means. The baseline corresponds to the lower limit of assay sensitivity. (c) Mice were infected as described for panel a. Imaging after
dissection was used to interpret live imaging signals. A representative image is shown for day 1 postinoculation. (d) Mice were infected as described for panel a.
Signals in dissected organs were quantitated over 10 days (3 mice per time point). Circles show individuals, and crosses show means. The baseline corresponds
to the lower limit of assay sensitivity. The neck signal came from the salivary glands. (e) BALB/c mice were infected i.p. with MCMV-LUC (105 PFU) and imaged
after 5 days. Live imaging showed strong abdominal signals. Imaging after dissection showed that these signals came mainly from the omentum, but other
intra-abdominal organs also were positive, including the spleen. Representative images are shown from 6 mice.
MCMV Lymph Node Infection
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localized extensively with CD169 (sialoadhesin, Siglec-1). EGFP
also showed colocalization with CD68 (an intracellular macro-
phage/granulocyte marker), CD206 (the mannose receptor), and
F4/80 (a tissue macrophage marker) (32). There was little colocal-
ization with the fibroblast marker ER-TR7 and none with B220 (B
cells).
Myeloid populations are rarely uniform in glycoprotein ex-
pression, but generally SSM and medullary sinus macrophages
(MSM) express CD169, while MSM and medullary cord macro-
phages (MCM) express F4/80 (17). MSM express more CD206
than do SSM. Therefore, the main infection target for i.f. MCMV
in PLN was SSM. At day 3 postinoculation, viral EGFP expression
remained mainly peripheral in the PLN, but there was a striking,
general loss of CD169 expression that significantly reduced EGFP/
CD169 colocalization. Colocalization with CD68, CD206, and
F4/80 was preserved, and there was significantly more colocaliza-
tion with ER-TR7. Thus, infection appeared to progress, albeit
slowly, from SSM to PLN fibroblasts.
MCMV lytic antigen-positive cells were seen occasionally
around the PLN margins but were much less evident than EGFP
cells (10% total numbers) (Fig. 3c). This was consistent with
HCMV IE1-driven cassettes operating independently of the viral
lytic cycle (33) and argued that most MCMV-infected PLN cells
were not lytically infected. This agreed with PLN showing HCMV
IE1 promoter-driven luciferase signals similar to those of footpads
(Fig. 1) but yielding 10- to 100-fold fewer PFU (Fig. 2).
Staining infected lung sections established the efficacy of the
immune serum in detecting lytic infection (Fig. 3c). New lytic
antigen staining occurred in PLN as a pan-cellular distribution
(Fig. 3c, arrow). More PLN cells showed lytic antigens in a subcel-
lular distribution. This presumably reflected virions and infected
cell debris from the footpads being trapped by SSM without new
lytic infection. Thus, some of the PFU recovered from PLN pos-
sibly were virions arriving from the footpads rather than being
produced in the PLN. This did not change our conclusion that
MCMV spreads via LN but suggested that the restriction of virus
replication in PLN was more marked than was revealed by plaque
assays.
MCMV SSM infection is direct. To determine whether SSM
were direct infection targets, we used i.f. virions in which HCMV
IE1 promoter-driven -galactosidase (-gal) disrupts the coding
sequence of an essential virion component, glycoprotein L (gL)
(34). The virions were pseudotyped gL by growth in comple-
menting cells and were infectious and could make new virions, but
a lack of gL rendered any new virions noninfectious. Thus, infec-
tion was restricted to the first cells encountered. Immunostaining
for-gal (Fig. 4a and b) showed infection around the PLN margin
that colocalized mainly with CD169 and CD68. Lytic antigens,
from either input virions passing along the lymphatics or the sin-
gle gL replication cycle, also were visible around the subcapsular
sinus (Fig. 4a). The similar distributions of gL and gL infections
supported the idea that replication-competent MCMV spreads
poorly within the PLN.
At 6 h postinoculation, infectious gL MCMV could be recov-
ered from both footpads and PLN (Fig. 4c), implying a direct
passage of inoculated virions to the PLN. At 24 h postinoculation,
infectious gL MCMV was detected only in footpads. In contrast,
gL PLN titers increased from 6 h to 24 h postinoculation, con-
sistent with virus replication. However, this did not necessarily
occur in the PLN, as footpad plaque titers also increased and were
FIG 2 Kinetics of MCMV infectivity and DNA spread. (a) BALB/c mice
were infected i.f. (105 PFU) with MCMV-LUC. Titers of infectious virus in
organs were determined by plaque assay. Horizontal lines show means, and
other symbols show individual mice. The dotted line shows the lower limit
of assay sensitivity. Results shown are titers from spleens, PLN, and foot-
pads on all days tested (P  0.0001), except for spleens and PLN at day 1,
when titers were very low. (b) Mice were infected as described for panel a.
The viral DNA copy number was quantitated by PCR of extracted DNA as
indicated. Horizontal lines show means, and other symbols show individ-
ual mice. Naive mice and day 5 i.p. infections (105 PFU) provided controls.
Numbers of viral DNA copies were significantly higher in infected than in
naive mice (P 0.001), except for spleens on day 1 (P 0.05). Numbers of
viral DNA copies in blood were significantly higher in mice infected i.p.
than at any time in mice infected i.f. (P  0.0001). (c) C57BL/6 mice were
infected i.f. (105 PFU) with MCMV-GR. Organs were plaque assayed as
described for panel a. Horizontal lines show means, and other symbols
show individual mice. The dotted line shows the lower limit of assay sen-
sitivity. Titers were significantly lower in spleens than in PLN at days 1 and
3 (P  0.001) and significantly lower than those of footpads on all days
(P  0.0001).
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10- to 100-fold higher than PLN titers. The gL viral DNA load in
PLN did not decline from 6 h to 24 h (Fig. 4d), presumably be-
cause gL MCMV produces new (noninfectious) virions. Both
gL and gL viral DNA loads in blood were low at 6 h and 24 h.
The gL input (6 h) appeared to be higher, but only gL DNA
loads increased from 6 h to 24 h. Viral DNA loads were consis-
tently at least 100-fold lower in blood than in the PLN, and there
was negligible infectious virus in blood.
FIG3 In situ analysis of PLN infection after i.f. MCMV. (a) C57BL/6 mice were given MCMV-GR i.f. (106 PFU). PLN taken 1 or 3 days later were stained for viral
EGFP (green) and cell type markers as indicated (red). Arrows show examples of colocalization. Nuclei were stained with Hoechst 33342 (blue). Scale bars show
50m. The upper left panels show whole-PLN overviews, with nuclear staining omitted for clarity, showing loss of CD169 staining at day 3. (b) Quantitation of
colocalization for which panel a shows examples. Five to 12 fields of view were examined from at least 3 separate PLN. From day 1 to day 3, the proportion of
EGFP cells that were CD169 decreased significantly (***, P 0.001), and the proportion that were ER-TR7 increased significantly (*, P 0.05). (c, upper)
Lung sections of C57BL/6 mice 3 days after MCMV-GR inhalation. (Lower) PLN on day 1 of infection with fewer lytic antigen cells (red) than EGFP cells
(green) (10% total numbers). The arrow shows an example of colocalization (an EGFP lytically infected cell).
MCMV Lymph Node Infection
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SSMs provide a functional barrier to MCMV spread. To test
functionally the contribution of SSM to MCMV host coloniza-
tion, we depleted them by injecting i.f. clodronate-loaded lipo-
somes 3 to 5 days before MCMV-LUC. This had little effect on
MCMV-LUC infection, as judged by live imaging (Fig. 5a). Imag-
ing dissected tissues (Fig. 5b) similarly showed little effect of clo-
dronate on the colonization of footpads or PLN. However, spleen
colonization increased significantly. Viral DNA loads in the blood
also increased (Fig. 5c).
We next tracked the effects of clodronate treatment on
C57BL/6 mouse colonization by gL (MCMV-GR) and gL vi-
ruses. For MCMV-GR (Fig. 6a), plaque assays showed an increase
in footpad, PLN, and spleen colonization, with the greatest in-
crease (100-fold) in PLN. Viral DNA loads in the blood also
increased (Fig. 6b), consistent with the results for MCMV-LUC
(Fig. 5b). The increase in MCMV-GR plaque titers in PLN at 1 day
postinoculation, without a corresponding increase in MCMV-
LUC luciferase signals (Fig. 5b), suggested that in clodronate-
treated mice PLN infection was more lytic, as luciferase expression
was from a lytic cycle-independent promoter. Consistent with this
idea, in situ analysis of MCMV-GR infection (Fig. 6c) showed no
significant change in the total number of cells expressing HCMV
IE1 promoter-driven EGFP. However, the distribution of EGFP
expression changed, from around the subcapsular sinus to nearer
PLN follicles, as defined by B220 staining. Clodronate treatment
depleted CD169 cells from the subcapsular sinus, so EGFP/
CD169 colocalization was lost. MCMV antigen cells were more
numerous, and, like EGFP cells, were seen further within the LN
substance. Here, ER-TR7 staining was increased, with a less
ordered distribution than that in control infected PLN, where
it was confined largely to the subcapsular sinus. EGFP cells
were closely associated with the abnormal ER-TR7 staining,
suggesting that in clodronate-treated mice, MCMV infected
PLN fibroblasts. Costaining for ER-TR7, EGFP, and lytic anti-
gens (Fig. 6d) revealed that many of the EGFP fibroblasts were
lytically infected.
X-Gal staining (based on HCMV IE1 promoter-driven viral
-gal) showed a similar penetration into the PLN of replication-
FIG 4 Direct infection of SSM. (a) C57BL/6 mice were infected i.f. with MCMV in which a -galactosidase expression cassette disrupts gL (gLgal) (106 PFU).
PLN harvested 24 h later were stained for lytic antigens (MCMV) or-gal to identify infection (green) and for cell type-specific markers to localize it (red). Nuclei
were stained with Hoechst 33342. Arrows show examples of colocalization. Scale bars show 50 m. (b) Colocalization, as illustrated in panel a, was quantitated
across 5 to 7 fields of view from PLN of 3 mice. Circles show individual counts, and horizontal lines show means. (c) C57BL/6 mice were infected i.f. with either
gL -gal MCMV or gL MCMV-GR as a control (106 PFU). Titers of infectious virus in organs were determined by plaque assay 6 or 24 h later. Circles show
individual mice, and horizontal lines show means. Preformed infectious gL -gal MCMV was detectable at 6 h, but titers then fell significantly from 6 to 24 h
(***, P 0.001). MCMV-GR titers in PLN increased significantly over the same period (*, P 0.05). The dotted line shows the limit of assay detection. (d) Mice
were infected as described for panel c, and viral DNA loads were quantitated by PCR. gL -gal DNA loads were maintained. All DNA loads in blood were low,
but those of MCMV-GR increased significantly from 6 to 24 h (***, P 0.001). The baseline corresponds to the lower limit of assay detection.
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deficient (gL) MCMV after clodronate treatment (Fig. 6e). One
hundredfold more gL-infected cells (X-Gal) were detected in
the spleens of clodronate-treated mice, indicating that SSM deple-
tion also allowed direct viral spread from footpad to spleen.
Therefore, by virion capture from the afferent lymph, SSM re-
stricted the spread of i.f. MCMV into the PLN and the blood. The
spread of gL MCMV argued that without this capture, virions
simply flow along LN channels to the efferent lymphatics.
CD169 cell depletion confirms the importance of SSM in
MCMV containment. Clodronate-loaded liposomes deplete
phagocytic cells generally rather than just SSM and can affect B cell
responses (35). Therefore, to confirm the importance of SSM for
containing i.f. MCMV, we depleted CD169 by diphtheria toxin
(DTx) treatment of CD169-DTx receptor (DTR) transgenic mice
(22) (Fig. 7). Again, virus loads increased: plaque assays at day 1
postinoculation showed modest increases in footpad and PLN
titers and a marked increase in splenic titers. (DTx depletes cells
much more rapidly than do clodronate-loaded liposomes, so we
could look earlier in infection, before virus replication built up
high titers in the PLN.) Thus, in the absence of CD169 cells,
MCMV passed rapidly from footpad to spleen. DTx may have
increased splenic viral loads more than liposomal clodronate did,
because it also depletes CD169 splenic metallophilic marginal-
zone macrophages (MZM), whereas i.f. clodronate does not (23).
Nonetheless, increased splenic infection established that the PLN
infection bottleneck was CD169 cell dependent, consistent with
a key role for SSM.
Genetic tagging shows little MCMV replication in CD11c
cells. The limited MCMV lytic antigen expression of SSM argued
that their infection is poorly productive. As a more direct measure
of virus production in myeloid cells, we infected CD11c-cre mice
(21) with MCMV-GR. Cre recombinase switches MCMV-GR
from green (EGFP) to nuclear-targeted red (tdTomato) fluoro-
chrome expression, and SSM express CD11c, as they are depleted
by DTx in CD11c-DTR mice (36). We depleted mice of SSM with
i.f. liposomal clodronate before infection with MCMV-GR. After
1 day, the virus recovered from PLN and spleens was unswitched,
regardless of clodronate treatment (Fig. 8a).
Immunostaining PLN sections showed that up to 40% of flu-
orescent cells in undepleted, infected mice expressed nuclear
tdTomato (Fig. 8b, control). This was consistent with SSM ex-
pressing CD11c and argued further that SSM infection produced
few new virions. Most tdTomato CD169 cells around the sub-
capsular sinus also were EGFP (Fig. 8b, upper, control, large
arrows), implying delayed or incomplete switching of infecting
genomes. Fully switched infected cells (EGFP tdTomato; small
arrows) were deeper in the PLN and CD169 cells, consistent with
MCMV also infecting CD11chi dendritic cells. The lack of
switched progeny virions (Fig. 8a) argued that this infection also
was poorly productive. Some viral lytic antigen staining (Fig. 8b,
lower, control) was associated with the part-switched cells around
the subcapsular sinus (large arrows). None was associated with the
fully switched cells (small arrows). Thus, CD11chi dendritic cells
seemed to switch viral genomes more efficiently than CD11clo
SSM in CD11c-cre mice, but neither cell type contributed signif-
icantly to new virus production. (Because fluorochrome expres-
sion was from a lytic cycle-independent promoter, cells could be
fluorescent without lytic infection.)
In mice treated with clodronate-loaded liposomes before i.f.
MCMV-GR (Fig. 8b, clodronate), CD169 expression was lost,
EGFP  cells appeared deeper within the PLN than the subcapsu-
lar sinus, and essentially all of these cells were EGFP tdTomato.
Thus, infection shifted to a CD11c cell, whereas results shown in
Fig. 6 indicate a shift to a fibroblast. Many of the EGFP cells
expressed MCMV lytic antigens (Fig. 8b, lower, clodronate). Den-
dritic cells resist depletion by clodronate-loaded liposomes be-
cause they are poorly phagocytic (23). However, they receive an-
tigens from SSM (18), and herpesviruses exploit immune
communication pathways to spread (37), so the loss of
tdTomato cells in PLN of clodronate-treated mice possibly re-
flected that MCMV reaches dendritic cells via SSM.
As control infected mice showed substantial MCMV-GR
switching in situ on PLN sections at day 1 postinoculation (Fig.
8b), we assayed their subsequent production of switched infec-
tious virus at day 3 (Fig. 8c). Virus titers were substantially higher
than they were at day 1, but switched virus remained1% of the
FIG 5 SSM depletion increases MCMV dissemination. (a) BALB/c mice were injected i.f. with clodronate-loaded liposomes (clod), or were left untreated (cont),
at 5 and 3 days prior to i.f. inoculation with MCMV-LUC (105 PFU). Mice were imaged for light emission 1 and 2 days later. Circles show individuals, and crosses
show means. No significant difference was observed between clodronate-treated and untreated mice (P 0.05). (b) Mice infected as described for panel a were
dissected for imaging of individual organs. Clodronate has no significant effect on footpad infection but increased PLN infection at day 2 (P 0.05) and increased
spleen infection at both time points (P 0.001). Dashed lines show the lower limit of assay sensitivity. (c) Mice were left untreated or were treated with clodronate
liposomes and infected as described for panel a, and viral DNA was quantitated in blood by PCR 1 day later. Circles show individual mice, and horizontal lines
show means. Clodronate treatment significantly increased viral DNA loads in blood (P 0.05).
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FIG 6 SSM depletion alters MCMV distribution in the PLN. (a) C57BL/6 mice were left untreated (closed symbols) or were given clodronate-loaded liposomes
i.f. 5 and 3 days before i.f. infection with MCMV-GR (106 PFU). One day later, footpads (n	 12), PLN (n	 7), spleens (n	 5), and blood (n	 5) were harvested
and plaque assayed for infectious virus. Horizontal lines show means, and other symbols show individual mice. The dotted line shows the lower limit of virus
detection. Clodronate treatment significantly increased virus titers in footpads, PLN, and spleens (***, P 0.001). (b) Mice were given liposomal clodronate i.f.
(clod) or were left untreated (cont), and then they were infected with MCMV-GR as described for panel a. One day later, viral DNA loads in blood were
quantitated by PCR. Clodronate treatment significantly increased the viral DNA load (*, P 0.05). (c) Mice were treated with clodronate or left untreated and
infected with MCMV-GR as described for panel a. PLN sections were stained for virus-expressed EGFP (green) and cell type markers or viral lytic antigens
(MCMV) (red). Nuclei were stained with Hoechst 33342. (Top) Low-power images without nuclear staining show the overall distribution of EGFP, with an area
of deeper penetration in clodronate-treated mice outlined. Arrows in the higher-power images show examples of colocalization. Scale bars show 50 m.
Clodronate treatment depleted CD169 cells from the subcapsular sinus and led to viral EGFP colocalizing with the fibroblast marker ER-TR7. (d) Mice were left
untreated or were treated with clodronate and infected with MCMV-GR as described for panel a. PLN sections were stained for virus-expressed EGFP (green),
viral lytic antigens (MCMV) (yellow), and the fibroblast marker ER-TR7 (red). Nuclei were stained with Hoechst 33342. Arrows show examples of lytically
infected fibroblasts, which were much more numerous after clodronate treatment (5-fold increase). (e) C57BL/6 mice were depleted of clodronate or left
untreated, as described for panel a, and then infected i.f. with replication-deficient gL-gal MCMV. Virus infection on tissue sections was revealed by X-Gal
staining. Infection again penetrated deeper into the PLN cortex after clodronate treatment (regions outlined). Spleens also showed significantly more infected
cells (20.3
 12.1 per low-power field and 0.3
 0.1 for untreated controls [means
 SEM, n	 6]) (P 0.001).
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total in all sites. Therefore, CD11c cells, which included SSM,
poorly supported MCMV replication. Staining LN infected for 1
day confirmed that CD169 cells express CD11c (Fig. 8d) and
showed virus-expressed EGFP in both CD11c CD169 and
CD11cCD169 cells (Fig. 8e), but infection of neither cell subset
contributed significantly to infection reaching the spleen.
DISCUSSION
Most analyses of host colonization by MCMV have used i.p. or i.v.
inoculations. These deliver virions directly to the blood. How
MCMV (or HCMV) first reaches the blood from peripheral sites
has been unclear. i.f.-inoculated MCMV spread via draining LN.
We saw no evidence of direct vascular spread bypassing LN infec-
tion. Inoculating replication-deficient MCMV established SSM as
a direct infection target. CMVs classically replicate in differenti-
ated myeloid cells (38), but SSM allowed little viral replication,
and their depletion increased acute infection spread. This increase
was associated with an infection of stromal cells rather than other
myeloid cells. Thus, SSM infection constituted a significant bot-
tleneck in MCMV dissemination after i.f. inoculation.
MCMV spread conformed essentially to the model established
for ectromelia virus (39): peripheral infection, primary viremia,
myeloid infection, secondary viremia, and then dissemination to
tertiary shedding sites. i.p. and i.v. MCMV inoculations directly
establish a primary viremia. After i.f. inoculation, LN infection
intervened. Within PLN, MCMV capture by SSM paralleled a sim-
ilar capture of i.f.-inoculated viruses that have not evolved to col-
onize mice (18–20). Such convergence of spread between un-
adapted and host-adapted viruses reflects that the routes are set at
least as much by the host as by viral functions. Antigens from most
tissues reach the blood via LN, so this is the main route taken by
viruses whose tropism promotes systemic spread.
LN both prime adaptive immunity and function as protective
filters to stop pathogens from reaching the blood. SSM were not
wholly effective filters; nonetheless, they substantially slowed the
spread of i.f.-inoculated MCMV by poorly supporting productive
infection and by restricting access to permissive fibroblasts. Fibro-
blasts were infected to a degree in the presence of SSM, but they
were infected much more readily and apparently lytically when
SSM were depleted. Limited switched virus production in CD11c-
cre mice, despite in situ evidence of switching in SSM and den-
dritic cells, argued that fibroblasts are the main LN site of MCMV
replication.
Myeloid cells generally do not enter efferent lymphatics (40),
and LN myeloid cells presumably die in situ after antigen presen-
tation. Therefore, MCMV may spread from LN as cell-free virions
rather than in myeloid cells. The contrasting, myeloid-associated
viremia of i.p. MCMV (13) could result from virions directly
reaching monocyte precursors in the bone marrow or from in-
fected peritoneal macrophages entering the thoracic duct. Cell-
free virions can exit the circulation via sinusoidal capillaries. These
occur in the spleen, bone marrow, salivary glands, liver, LNs, ad-
renals, and pancreas. Therefore, an early, cell-free viremia could
infect these sites before bone marrow-derived monocytes become
the main means of virus spread. Murid herpesvirus 4 (MuHV-4)
similarly establishes a cell-free primary viremia after seeding to
and then replicating in LN (37). However, CD11c cell infection
(41) plays a more prominent role in LN infection than it did with
MCMV, and in the long term MuHV-4 disseminates primarily via
infected B cells (42).
The containment of i.f.-inoculated MCMV by SSM paralleled
the containment of systemically inoculated MCMV by splenic
MZM (43, 44), consistent with SSM and MZM analogously filter-
ing the afferent lymph and blood. MCMV containment by SSM
further paralleled their containment of i.f. VSV (45). That SSM
and MZM generally restrict virus spread suggests a generic defense
mechanism. SSM were infected within 6 h of MCMV inoculation,
so this was unlikely to be adaptive immunity; rather, the delay
imposed by SSM allowed time for adaptive priming to occur. NK
cells help to control MCMV replication in SSM (46), but they are
not immediately effective (47), and while NK cells restrict m157
MCMV spread in C57BL/6 mice (30), SSM limited m157 virus
spread in both BALB/c and C57BL/6 mice. Thus, an intrinsic
mechanism seemed more likely, as proposed for MZM restricting
i.p. MCMV (44).
The alpha/beta interferons (IFN) are one candidate, as SSM
prominently express IFN in response to viral infection (48), and
IFN can restrict MCMV spread in vivo (49–51). High MZM ex-
pression of USP18, which negatively regulates the IFN-dependent
effector ISG15 (52), may reflect a cytoprotective adaptation to
strong IFN responses (53) in cells abundantly exposed to incom-
ing viruses; widespread loss of CD169 expression 3 days after i.f.
MCMV, when viral lytic replication was far from extensive, sug-
gested a host response, such as IFN-dependent apoptosis, rather
than a direct viral effect, and the failure of SSM to restrict MCMV
replication completely perhaps reflected viral IFN evasion. How-
ever, other mechanisms are equally possible, so this requires fur-
ther investigation. Although HCMV lytic reactivation can be in-
duced in vitro by monocyte differentiation (38), the poor lytic
replication of MCMV in SSM and LN dendritic cells implied that
in vivo, other factors also are important. The capacity of SSM to
restrict the spread of i.f.-inoculated MCMV suggested that muco-
sally inoculated MCMV bypass SSM. Dendritic cells, which can
migrate between SSM (54) and disseminate MuHV-4 (41),
seemed not to disseminate MCMV, but migratory CD11c my-
eloid cells are a possible means of transport. The present data
establish that for i.f.-inoculated MCMV, spread occurs via LN and
SSM are a direct and rate-limiting infection target.
FIG 7 CD169 cell depletion promotes MCMV spread. CD169-DTR mice
were left untreated (closed symbols) or were given diphtheria toxin i.p. (open
symbols) at 3 and 1 days before i.f. infection with MCMV-GR (106 PFU). Two
days later, organs were plaque assayed for infectious virus. Horizontal lines
show means, and other symbols show individual mice. The dashed line shows
the limit of virus detection. Clodronate treatment significantly increased the
virus titers in PLN (**, P 0.01), footpads, and spleens (***, P 0.001). The
dotted line shows the limit of assay sensitivity.
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FIG 8 Viral fluorochrome switching reveals MCMV infection of CD11c cells but little evidence of MCMV replication. (a) CD11c-cre mice were depleted of SSM by
i.f. injection of clodronate-loaded liposomes (clod) or were left untreated (cont), and then all mice were infected i.f. with MCMV-GR (106 PFU). PLN and spleens
harvested 1 day later were plaque assayed for EGFP and tdTomato virus. Only unswitched (EGFP) virus was detected. Horizontal lines show means. Other symbols
show individual mice. The dotted line shows the limit of assay sensitivity. Clodronate treatment significantly increased (unswitched) virus titers in PLN (***,
P 0.001). (b) CD11c-cre mice were left untreated (control) or were depleted of SSM by i.f. liposomal clodronate 5 and 3 days before i.f. MCMV-GR inoculation (106
PFU). PLN harvested 3 days later were stained for EGFP (green), tdTomato (red), and CD169 or MCMV lytic antigens (MCMV) (yellow). In the upper control panel,
large arrows show CD169 cells around the subcapsular sinus that express both EGFP and nuclear tdTomato (partially switched). Small arrows show completely
switched cells that are CD169. Clodronate treatment removed CD169 staining from the subcapsular sinus. Cells just below the sinus became infected and were
unswitched. Lytic antigen staining was seen around the subcapsular sinus in control mice (lower panel, large arrows) and was associated with partial switching.
Completely switched cells showed no lytic antigen staining (small arrows). After clodronate treatment, lytic antigen staining was seen further into the PLN cortex in cells
infected with unswitched virus. Scale bars show 50m. (c) CD11c-cre mice were infected i.f. with MCMV-GR (106 PFU). Footpads, PLN, and spleens harvested 3 days
later were plaque assayed for EGFP (green) and tdTomato (red) viruses. Horizontal lines show mean titers for each. Other symbols show individual mice. Switched
virus (red) accounted consistently for1% of the total. The dotted line shows the limit of assay sensitivity. (d) C57BL/6 mice were infected i.f. with gL MCMV (106
PFU). PLN harvested 2 days later were stained for CD169 (red in the merged image) and CD11c (green in the merged image). Nuclei were stained with Hoechst 33342
(blue). Scale bars, 20 m. Arrows show examples of colocalization (CD169 CD11c SSM). (e) C57BL/6 mice were infected i.f. with MCMV-GR (106 PFU). PLN
harvested 2 days later were stained for CD169 (cyan in the merged image), CD11c (blue in the merged image), and viral EGFP (green in the merged image). Viral EGFP
is seen in a CD11c CD169 dendritic cell (large arrowhead) and CD11c CD169 SSM (small arrows).
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